about
Apolipoprotein O is mitochondrial and promotes lipotoxicity in heartIncreased Tpeak-Tend interval is highly and independently related to arrhythmic events in Brugada syndrome.Who are patients classified within the new terminology of heart failure from the 2016 ESC guidelines?Blood signature of pre-heart failure: a microarrays study.Metabonomics analysis of plasma reveals the lactate to cholesterol ratio as an independent prognostic factor of short-term mortality in acute heart failure.B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode.Acute electromyostimulation decreases muscle sympathetic nerve activity in patients with advanced chronic heart failure (EMSICA Study)Direct evidences for sympathetic hyperactivity and baroreflex impairment in Tako Tsubo cardiopathy.The prognostic value of plasma galectin-3 in chronic heart failure patients is maintained when treated with mineralocorticoid receptor antagonistsBenefits of cardiac rehabilitation in heart failure patients according to etiology: INCARD French study.Serum levels of mitochondrial inhibitory factor 1 are independently associated with long-term prognosis in coronary artery disease: the GENES StudyResearch of predictive factors for cardiac resynchronization therapy: a prospective study comparing data from phase-analysis of gated myocardial perfusion single-photon computed tomography and echocardiography : Trying to anticipate response to CRT.New concept of myocardial longitudinal strain reserve assessed by a dipyridamole infusion using 2D-strain echocardiography: the impact of diabetes and age, and the prognostic value.Prognostic value of systolic short-term blood pressure variability in systolic heart failureIncreased mean aliphatic lipid chain length in left ventricular hypertrophy secondary to arterial hypertension: A cross-sectional study.Efficacy and safety of alcohol septal ablation in patients over 65 years old with obstructive hypertrophic cardiomyopathy.Early Prediction of 3-month Survival of Patients in Refractory Cardiogenic Shock and Cardiac Arrest on Extracorporeal Life Support.Bortezomib and heart failure: case-report and review of the French Pharmacovigilance database.Diagnosis and treatment of iron deficiency in patients with heart failure: expert position paper from French cardiologists.Intramyocardial transplantation of mesenchymal stromal cells for chronic myocardial ischemia and impaired left ventricular function: Results of the MESAMI 1 pilot trial.Coronary artery calcification: From crystal to plaque rupture.Serum allantoin and aminothiols as biomarkers of chronic heart failure.Prognosis Impact of Frailty Assessed by the Edmonton Frail Scale in the Setting of Acute Coronary Syndrome in the Elderly.Non-vitamin K antagonist oral anticoagulants and heart failure.A family history of dilated cardiomyopathy induced by viral myocarditis.Association between serum alkaline phosphatase and coronary artery calcification in a sample of primary cardiovascular prevention patients.Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.Homocysteine in Chronic Heart Failure.The medical history of adults with complex congenital heart disease affects their social development and professional activity.Obesity Paradox: Origin and best way to assess severity in patients with systolic HF.First evidence of increased plasma serotonin levels in Tako-Tsubo cardiomyopathy.Takotsubo cardiomyopathy in a squash player.Prediction of all-cause mortality from gated-SPECT global myocardial wall thickening: comparison with ejection fraction and global longitudinal 2D-strain.[Cardiotoxicity of chemotherapies].Transcatheter aortic valve implantation reduces sympathetic activity and normalizes arterial spontaneous baroreflex in patients with aortic stenosis.Relation between left ventricular outflow tract obstruction and left ventricular shape in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.Slower heart rate and altered rate dependence of ventricular repolarization in patients with lone atrial fibrillation.Relationship between left ventricular sphericity and trabeculation indexes in patients with dilated cardiomyopathy: a cardiac magnetic resonance study.[Interest of NT-proBNP in chronic heart failure follow-up].High-intensity interval exercise improves vagal tone and decreases arrhythmias in chronic heart failure.
P50
Q24294870-824A7D55-3561-4A88-A589-6AF6E347A2FEQ33166047-3387E422-EBAC-4785-BD9F-3AB3F46E5C1DQ33577412-E3B6BD15-4EDE-4C54-B5D3-658C4046AF94Q33952087-B005DB70-E318-44C9-A251-249EEBB297EBQ34662086-27C250F8-A4FE-4C70-A9C2-15AA3B26A6F5Q35000296-7C626B57-4A36-4D67-B40B-9DD80E113EFCQ35050477-64C8DCFE-B0E5-43A7-95C0-27118100F92CQ35131097-C6A1304D-EAC9-436B-B4C2-92E28F4A3CEFQ35191679-452C1522-7DB9-401C-88F2-6CE020083E33Q36009581-481D778E-DA76-46A0-8367-40F9348D37DCQ36110734-37E0F774-2B89-4E5F-9C2C-94C7162382C2Q36280691-5511FB7D-B76F-4DA0-8359-B33A01E48D2DQ36937350-FC5C48BE-1E02-423B-B51C-257395B80647Q37090096-AE7E65DE-24D0-47CB-9850-19AE85DF36C3Q37432845-0B6548BE-A7C2-4B33-86A6-E3C4BD099C68Q37691628-B6A24421-C3FE-44F0-A780-B792B5BA79A0Q37717673-785667EE-D5D3-4E12-8BBD-BD628AF3D836Q38115568-6213F507-CA6D-46A1-A4CD-F0140D7F2A10Q38252749-9866F84A-0132-427B-AADF-420ACD098D66Q38395633-E87ACC3C-9161-45CD-AAA5-0810F50F069EQ38666015-4BF66B2A-ACA1-4FBA-8BA0-EFFC3BE7C978Q38680533-E8B8FECD-196F-4C54-859D-EC6F48682A47Q38698718-099BB67A-0926-4D8D-BB46-D976AFE1E47AQ39005851-7401F685-49F4-407C-8430-ED6D8C24F29CQ39175203-BC1000AA-9B31-4950-9F03-93218B856824Q40260672-1A97A730-4AF2-469F-973D-5ACBD3CA57CEQ40537439-508EC81B-AEB9-4947-A326-A455BA10F125Q41135904-98C00DCC-A2A9-4501-8CB8-9B7371E4A47BQ41365831-52858A7A-E212-45FE-A9BD-E158286365BDQ41421408-42253163-2420-4B07-9FC0-5FCE2A9D37D8Q41774024-842F30E9-654A-448B-A142-AA3294F442EAQ41854839-957765E1-81EB-4F2E-8D3A-61075255C719Q43498556-65BF01EE-1952-40B0-9E78-EC7C03DE8697Q44099931-091A36A5-6153-47AE-955B-A76DB6944401Q44103004-A0C0D067-099F-4D0D-B102-FE8A27711566Q44123946-141E05EF-A9D8-476E-80C7-DBBF3B47B997Q44665983-796BEA1C-DFE6-400D-9CFC-E2B026B42730Q45019041-552845BF-E0BA-43FA-9CC4-F4F70D308ABAQ45959946-8EAC915A-C61B-4B5C-89AB-C5F57C51EF46Q46482563-87F1C3EF-960B-43D6-9016-5F823F454B4B
P50
description
investigador
@es
researcher
@en
name
Michel Galinier
@en
type
label
Michel Galinier
@en
prefLabel
Michel Galinier
@en
P31
P496
0000-0003-1735-3390